A Peter, M Shipkova, E Wieland… - Clinical …, 2011 - Am Assoc Clin Chem A 9-year-old girl was admitted to our hospital with juvenile metachromatic leukodystrophy (arylsulfatase A deficiency). Symptoms of this lysosomal storage disease, such as decreased school performance and compromised motor skills, had started 1 year earlier. She underwent bone marrow ... Related articles - All 3 versions
R Walker, I Ruderman, R Masterson… - NDT …, 2011 - ndtplus.oxfordjournals.org INTRODUCTION AND AIMS: Impaired glucose metabolism manifest as new onset diabetes after transplantation (NODAT) and impaired glucose intolerance (IGT) is a common and important unwanted outcomes with potential impacts on cardiovascular risks, infections and ...
Y Inamoto, MED Flowers, FR Appelbaum… - Biology of Blood and …, 2011 - Elsevier This retrospective study was carried out to compare results with tacrolimus versus cyclosporine in combination with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation (HCT) with granulocyte colony-stimulating factor-mobilized blood cells. ... Related articles - All 4 versions
SR Erdem, S Emre-AydIngöz, P Atilla, AN Çakar… - Life sciences, 2011 - Elsevier To bring further insight into the mechanism of cyclosporine A (CsA)-induced hepatotoxicity, the acute effect of CsA on local hepatic blood flow (LHBF) and its association with systemic hemodynamics, histopathological and biochemical indicators of liver toxicity were studied ... All 3 versions
M Cortinovis, E Gotti, S Pradini, F Gaspari… - Transplantation, 2011 - journals.lww.com Methods. One hundred thirty-five complete MPA profiles were sequentially collected from 56 kidney transplant recipients given MMF and low-dose CsA as part of their immunosuppressive therapy. MPA pharmacokinetic parameters were correlated with blood CsA area under ... Related articles - All 4 versions